Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP.
about
Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.Renal Drug Transporters and Drug Interactions.Drug-drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4.Clinical Pharmacokinetics and Pharmacodynamics of Micafungin.Influence of Experimental Cryptococcal Meningitis in Wistar Rats on Voriconazole Brain Penetration Assessed by Microdialysis.Determinants of the Magnitude of Interaction Between Tacrolimus and Voriconazole/Posaconazole in Solid Organ Recipients.Pharmacogenomics of triazole antifungal agents: implications for safety, tolerability and efficacy.Pharmacokinetic Drug Interactions of Apatinib With Rifampin and Itraconazole.Posaconazole tablets in real life lung transplantation: impact on exposure, drug-drug interactions and drug management in lung transplanted patients, including cystic fibrosis.Voriconazole more likely than posaconazole increases plasma exposure to sublingual buprenorphine causing a risk of a clinically important interaction.Clarifying busulfan metabolism and drug interactions to support new therapeutic drug monitoring strategies: a comprehensive review.Severe neurological disorders and refractory aspergillosis in an adolescent treated by vincristine and voriconazole.
P2860
Q38681635-7C94E293-3609-478D-A00A-D44511481A48Q39140289-2A665EE4-F250-4BB9-B455-CE4D14EAC1A8Q39443748-3888D446-9D71-4997-9859-C716FE53B44BQ40100873-DFDABE89-06F1-4EF0-9AEB-43AC636C597DQ40220942-5FED9272-2B91-46DF-A09A-1AEDB75124A5Q40322487-5FDFB9FC-7BCD-4195-A86B-EB3E8FC8C8ADQ47664190-CD8F1BB8-1CA5-4F7A-929F-9607018D363AQ47885966-302B3CF9-B13D-46E2-91DC-AA873369000FQ48294234-32850F17-1382-4E99-9583-5016B2685B6FQ51579656-F5FC201C-5510-4E09-87DC-63FCDDE4A158Q52552920-F7CA8F10-60D2-4E6D-8B0C-9FE130B55F8DQ53117928-1EE5C3EE-0ED9-4014-8D88-2BF254CB93F6
P2860
Inhibitory Potential of Antifungal Drugs on ATP-Binding Cassette Transporters P-Glycoprotein, MRP1 to MRP5, BCRP, and BSEP.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Inhibitory Potential of Antifu ...... MRP1 to MRP5, BCRP, and BSEP.
@en
type
label
Inhibitory Potential of Antifu ...... MRP1 to MRP5, BCRP, and BSEP.
@en
prefLabel
Inhibitory Potential of Antifu ...... MRP1 to MRP5, BCRP, and BSEP.
@en
P2093
P2860
P356
P1476
Inhibitory Potential of Antifu ...... MRP1 to MRP5, BCRP, and BSEP.
@en
P2093
David M Burger
Jan B Koenderink
Jeroen J M W van den Heuvel
Rob E Aarnoutse
Roger J Brüggemann
Vincent J C Lempers
P2860
P304
P356
10.1128/AAC.02931-15
P407
P577
2016-03-21T00:00:00Z